Division of Biology, Chemistry, and Materials Science, Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, Office of Medical Products and Tobacco, US Food and Drug Administration, Silver Spring, Maryland 20993, USA; email:
Annu Rev Anal Chem (Palo Alto Calif). 2018 Jun 12;11(1):307-327. doi: 10.1146/annurev-anchem-061417-125556. Epub 2018 Mar 26.
In the United States, regulatory science is the science of developing new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of all Food and Drug Administration-regulated products. Good regulatory science facilitates consumer access to innovative medical devices that are safe and effective throughout the Total Product Life Cycle (TPLC). Because the need to measure things is fundamental to the regulatory science of medical devices, analytical chemistry plays an important role, contributing to medical device technology in two ways: It can be an integral part of an innovative medical device (e.g., diagnostic devices), and it can be used to support medical device development throughout the TPLC. In this review, we focus on analytical chemistry as a tool for the regulatory science of medical devices. We highlight recent progress in companion diagnostics, medical devices on chips for preclinical testing, mass spectrometry for postmarket monitoring, and detection/characterization of bacterial biofilm to prevent infections.
在美国,监管科学是一门发展新工具、标准和方法的科学,用于评估所有食品和药物管理局监管产品的安全性、有效性、质量和性能。良好的监管科学有助于消费者获得安全有效的创新医疗器械,这些医疗器械在整个产品全生命周期(TPLC)内都是安全有效的。由于衡量事物的必要性是医疗器械监管科学的基础,分析化学发挥着重要作用,以两种方式为医疗器械技术做出贡献:它可以成为创新医疗器械的一个组成部分(例如诊断设备),也可以用于在整个 TPLC 中支持医疗器械的开发。在这篇综述中,我们重点介绍分析化学作为医疗器械监管科学的工具。我们强调了近年来在伴随诊断、用于临床前测试的芯片上医疗设备、用于上市后监测的质谱以及检测/表征细菌生物膜以预防感染方面的进展。